✦ LIBER ✦

Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis

✍ Scribed by Grant W. Cannon; John R. Ward; Daniel O. Clegg; Cecil O. Samuelson Jr.; Thomas M. Abbott

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 663 KB
Volume: 26
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780261015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate polyglutamate concentration

Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy

✍ Lisa K. Stamp; John L. O'Donnell; Peter T. Chapman; Mei Zhang; Jill James; Chris 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Clostridium difficile-associated diarrhe

Clostridium difficile-associated diarrhea in rheumatoid arthritis patients who are receiving therapy with low-dose chlorambucil

✍ Angel Ramos; Victor Manuel Martínez-Taboacla; Concepcion Fito; Vicente Rodriguéz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 2 views

Effect of food on the bioavailability of

Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis

✍ D. Oguey; F. Kölliker; N. J. Gerber; J. Reichen 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Objective. To evaluate the influence of food on the bioavailability of an oral dose of methotrexate in patients with rheumatoid arthritis. Methods. Methotrexate (15 mg) was given intravenously and orally, with or without a meal, to 10 patients. Blood samples were drawn at specific intervals to eval

Risk of interstitial lung disease associ

Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis

✍ Ji Hyeon Ju; Sung-Il Kim; Jun-Hee Lee; Sang-Il Lee; Wan-Hee Yoo; Jung-Yoon Choe; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Failure of low-dose intravenous immunogl

Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis

✍ Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w

Acute febrile toxic reaction in patients

Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine

✍ Ricardo Blanco; Victor M. Martínez-Taboada; Miguel A. González-Gay; Jose Armona; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Objective: To assess the frequency and clinical features of an acute febrile toxic reaction (aftr) in patients with refractory rheumatoid arthritis (ra) receiving combined therapy with methotrexate (mtx) and azathioprine (aza). ## Methods: A cohort of 43 ra patients being treated with mtx/aza